Adenoid Cystic Carcinoma of the Bartholin’s Glands: A Literature Review
Brazilian Journal of Oncology · 26.06.2026 · 22 (CP)
DOI: 10.1055/s-0046-1825296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brazilian Journal of Oncology, erschienen am 26.06.2026. Verfasst von Valeria Mata de Duarte Ferreira Ribeiro und 8 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window) Address for correspondence Valeria Mata de Duarte Ferreira Ribeiro (valeriamdfr@gmai.com)
Introduction
Adenoid cystic carcinoma (ACC) of the Bartholin's glands (GB) is rare, representing 10 to 15% of malignant tumors of these glands and 2 to 7% of all vulvar malignancies. Previously called cylindroma, it presents slow growth, a high rate of local recurrence, and a significant potential for late metastasis, mainly to the lungs and bones .
Objective
To review the literature to understand the behavior of this rare tumor and outline optimal therapeutic strategies . Methodology: Searches were conducted in the PubMed, Lilacs – BVS, and Scielo databases using the descriptors: ((Vulva) OR (Bartholin's Glands)) AND (Adenoid Cystic Carcinoma), selecting clinical trials, reviews, and case reports from the last 20 years, in English. It was found 48 results in PubMed, 4 in Lilacs, and none in Scielo. Studies on ACC in other locations or different types of vulvar tumors were excluded. The final selection included 31 articles: 3 reviews and 28 case reports. No clinical trials or meta-analyses were found .
Results
Surgery was the primary treatment in all cases, ranging from local excision to total pelvic exenteration. Regional lymphadenectomy was performed in 81.5% of cases, but its therapeutic value remains uncertain, as lymph node involvement is considered uncommon. Adjuvant radiotherapy was administered to 59.3% of patients in cases with positive margins, perineural invasion, or muscular invasion. Adjuvant chemotherapy was used in 25.9% of cases, with platinum-based regimens combined with taxanes or fluoropyrimidines and doxorubicin. Distant metastases occurred in 48.1% of cases between 2 and 5 years after initial treatment, with an overall survival rate of 18 to 30 months. Immunotherapy and targeted therapies have shown limited evidence of efficacy. Comparative data between chemotherapy and immunotherapy are scarce, but reports suggest that ACC may be resistant to immune checkpoint inhibitors due to low tumor mutational burden. Recurrences were higher with conservative and incomplete surgical approaches and in the absence of adjuvant therapy .
Conclusion
There is no consensus on the treatment of ACC in BG. Current approaches derive from surgery for squamous cell carcinoma of the vulva and treatments for ACC in other locations. Its rarity limits robust research, but the growing number of case reports demonstrates the need for more scientifically relevant studies. Multidisciplinary management is essential for better decision-making and better outcomes. Publication History Article published online: 26 June 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil Bibliographical Record Valeria Mata de Duarte Ferreira Ribeiro, Marttina Rossi Milão, Alexia Marques Rocha, Natalia de Azevedo Marques, Hugo de Carvalho Mandarino Junior, Amanda Silva Amaral, Lilia Freitas Oliveira, Daniela Gros e Silva Spada, Maria Laura Justi Spindola. Adenoid Cystic Carcinoma of the Bartholin’s Glands: A Literature Review. Brazilian Journal of Oncology 2026; 22. DOI: 10.1055/s-0046-1825296
Zitieren
APA
Ribeiro, V. M. D. D. F., Milão, M. R., Rocha, A. M., Marques, N. D. A., Junior, H. D. C. M., Amaral, A. S., Oliveira, L. F., Spada, D. G. E. S., & Spindola, M. L. J. (2026). Adenoid Cystic Carcinoma of the Bartholin’s Glands: A Literature Review. Brazilian Journal of Oncology, 22(CP). https://doi.org/10.1055/s-0046-1825296
Vancouver
Ribeiro VMDDF, Milão MR, Rocha AM, Marques NDA, Junior HDCM, Amaral AS, et al. Adenoid Cystic Carcinoma of the Bartholin’s Glands: A Literature Review. Brazilian Journal of Oncology. 2026;22(CP). doi:10.1055/s-0046-1825296
BibTeX
@article{Ribeiro2026,
author = {Ribeiro, Valeria Mata de Duarte Ferreira and Milão, Marttina Rossi and Rocha, Alexia Marques and Marques, Natalia de Azevedo and Junior, Hugo de Carvalho Mandarino and Amaral, Amanda Silva and Oliveira, Lilia Freitas and Spada, Daniela Gros e Silva and Spindola, Maria Laura Justi},
title = {Adenoid Cystic Carcinoma of the Bartholin’s Glands: A Literature Review},
journal = {Brazilian Journal of Oncology},
year = {2026},
volume = {22},
number = {CP},
doi = {10.1055/s-0046-1825296}
}
EUVIMED